FDA

• ‘No indication’ U.S. blueberry recall for death risk impacts Canada: CFIA

  A Class 1 FDA recall is when 'there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.'

  Canada

  5 hours
  
• U.S. FDA approves new breast cancer drug that could slow disease significantly

  Revtorpyk is intended to treat patients with advanced breast cancer whose tumors have low levels of a protein called HER2 and no mutation in a gene called PIK3CA.

  Health

  Jul 14
  
• Advertisement
• U.S. FDA approves Eli Lilly’s GLP-1 oral weight-loss pill

  The U.S. FDA said the drug was approved within 50 days of the company filing for approval, one of the fastest approval times for any drug.

  Health

  Apr 1
• Advertisement
• FDA approves another abortion pill, sparks conservative backlash

  The FDA approved the original version of mifepristone in 2000 and gradually eased access over time.

  U.S. News

  Oct 3, 2025
• Infant formula is under health review in the U.S. What parents should know

  The effort launched by U.S. Health Secretary Robert F. Kennedy Jr., dubbed “Operation Stork Speed," is the first deep look at the ingredients in formula since 1998.

  Health

  Jun 3, 2025
• Some acne products recalled in U.S. due to benzene, ‘no impact’ in Canada

  The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, though it stressed consumers faced little risk.

  Health

  Mar 14, 2025
• FDA cancels meeting on selecting strains for next season’s flu shot

  A meeting of a committee which advises the U.S. Food and Drug Administration on vaccine policy has been canceled, a committee member told Reuters.

  Health

  Feb 27, 2025
• Ozempic, Wegovy shortages are resolved in the U.S.: FDA

  The drugmaker Novo Nordisk can meet present and future demand in the U.S. for its drugs including Ozempic and Wegovy, the U.S. Food and Drug Administration said.

  Health

  Feb 21, 2025
• Advertisement
• The FDA wants these cold medicines off the shelves. Should Canada follow?

  The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may prompt Canada to review its approval of the drug.

  Health

  Nov 14, 2024
• Advertisement
• FDA launches probe after study finds trace toxic metals in tampon brands

  The U.S. FDA has launched an investigation into the safety of tampons following a study that found trace amounts of toxic metals, such as arsenic and lead, in various brands.

  Consumer

  Sep 11, 2024